TL;DR
Researchers at the University of Cambridge and start-up GlitterinTech report a compact, low-cost optical spectrometer designed to analyze light with high precision. Tests included material classification and measurements of several biomarkers, including glucose, but the reported demonstrations do not establish that the device is ready for medical use or can replace established glucose tests.
Researchers at the University of Cambridge and the start-up GlitterinTech say they have developed a roughly $10 optical spectrometer small enough to fit into portable electronics and potentially wearable devices. In reported tests, the chip measured several biomarkers, including glucose, but the results are research demonstrations, not evidence of an approved medical monitor.
Get everyday helpers delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The device, called a convolutional spectrometer, is built on a silicon nitride photonic platform and includes onboard electronics. It measures near-infrared light across wavelengths of 1,200 to 1,700 nanometres, with the team reporting that it can collect and process a measurement in less than a second. Optical spectrometers infer information about materials by measuring how they interact with light.
The researchers tested the instrument on materials and solutions. They report a 100% classification success rate for plastics, pharmaceuticals, coffee, flour and tea in their tests. For concentrations in water-based and organic solutions, they report accuracy of about 0.01%, which they say exceeded commercial benchtop spectrometers in those experiments. These figures describe the study’s test conditions; the source report does not provide enough detail to establish how performance would compare across broader, independent testing.
For biomedical demonstrations, the team says the device measured skin moisture, blood alcohol, blood lactate and blood glucose under conditions designed to reflect physiological environments. It also demonstrated noninvasive glucose tracking over an extended period in one participant. The report does not establish the device’s accuracy across a larger group or show that it can diagnose or manage diabetes. The researchers say further testing is needed before practical medical deployment.
Wearable Sensing Still Needs Validation
A compact spectrometer could make some chemical measurements possible outside a laboratory, if later testing confirms the reported performance. Potential uses named by the researchers include wearable health monitoring, food testing, industrial quality control and environmental sensing. A less expensive instrument could also make certain measurements easier to deploy in portable equipment rather than relying on larger benchtop systems.
The glucose demonstration is of particular interest because noninvasive tracking could reduce reliance on needle-based sampling for some users. But this study does not show that the chip is a dependable substitute for existing glucose meters or continuous glucose monitors. Medical use would require validation of accuracy, reliability and safety in larger, representative groups and under everyday conditions.
The team also reports operation between -20°C and 80°C, a broad temperature range that may be useful in outdoor or industrial settings. That capability, along with the compact size, is a technical result reported by the researchers; it does not by itself establish durability or performance in a finished consumer product.
Popular right now
Ninja Crispi 4-in-1 Portable Glass Air Fryer, Grey, FN101GY
LG StanbyME 2 Max 32-Inch 4K Portable Smart Touchscreen TV
Roborock Robot Vacuum and Mop with LiDAR Navigation and Self-Empty Dock
As an affiliate, we earn on qualifying purchases.
How the Convolutional Chip Works
Many conventional spectrometers separate incoming light into wavelengths or use calculations to reconstruct its spectrum. The Cambridge team’s design instead arranges optical components with repeating spectral responses so that the light is processed through a convolution-based approach. The components can include unbalanced Mach-Zehnder interferometers or micro-ring resonators. Fast Fourier transforms are then used to recover the spectrum.
The researchers say the approach may avoid some limitations that affect miniaturized spectrometers, such as restricted measurement ranges, lower resolution or reduced accuracy. They also report that adding optical components could increase resolution and extend spectral bandwidth without major hardware changes. Those are capabilities described by the team; how they translate to specific commercial products and costs remains to be established.
“The key insight was to go back to the mathematics and ask whether there was a fundamentally cleaner way to retrieve spectra.”
— Dr. Chunhui Yao, lead author
Clinical Evidence Remains Limited
The reported glucose tracking involved one participant, and the source report does not state the size or makeup of the other biomedical test groups. It also does not provide details here on comparison methods, error rates across participants, or how the device performed during routine daily activity. The reported 100% classification result and concentration accuracy apply to the experiments described, not necessarily to other samples or settings.
It remains unclear when a commercial device might be available, what the final product would cost, and whether the stated $10 figure covers the full wearable system or the sensor component alone. The report also does not describe regulatory review or provide a timeline for larger clinical studies. The researchers say additional testing is required before medical use.
Further Testing Before Medical Use
The next step is further evaluation of the sensor, particularly in biomedical settings where reliability across people and real-world conditions matters. The source report does not specify a schedule for larger studies, regulatory submissions or product launch. Until those details are available, the glucose results should be understood as an early demonstration rather than a validated consumer health feature.
Researchers and potential developers will also need to show how the device performs beyond the reported experiments, including whether its readings remain dependable over time and how a complete wearable system would be packaged and priced. For now, the confirmed development is a compact spectrometer prototype with promising reported tests; its eventual applications and readiness remain open questions.
Key Questions
What did the Cambridge researchers develop?
They developed a compact convolutional optical spectrometer on a silicon nitride photonic platform, with onboard electronics. The team says the sensor costs about $10 and operates in the near-infrared range.
Can the chip monitor blood glucose without needles?
The researchers demonstrated noninvasive glucose tracking over an extended period in one participant. That is a research result, not proof that the device is ready to replace established glucose-monitoring methods.
What did the material tests show?
The team reports a 100% classification success rate for five tested categories: plastics, pharmaceuticals, coffee, flour and tea. It also reports about 0.01% accuracy in concentration measurements in water-based and organic solutions. The results apply to the reported experiments.
When could it be available in a wearable?
No product release date is given in the source report. The researchers say further testing is needed before the technology can become a practical medical product.
Source: rss
